Jing Zhang , Dandan Liu , Chuanyu Jia , Shuyang Wang , Yuhui Li
{"title":"Danshensu sodium attenuates pyroptosis in ischemic stroke by targeting the HMGB1/RAGE axis and downstream NLRP3/GSDMD/ASC/Caspase-1 pathway","authors":"Jing Zhang , Dandan Liu , Chuanyu Jia , Shuyang Wang , Yuhui Li","doi":"10.1016/j.cyto.2026.157109","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Danshensu Sodium (DSS-S), the sodium salt of a principal water-soluble active compound from <em>Salvia miltiorrhiza</em>, was investigated for its effects on cerebral ischemic-reperfusion (I/R) injury and the underlying molecular mechanisms.</div></div><div><h3>Methods</h3><div>Neuroprotection by DSS-S was evaluated <em>in vivo</em> using a transient middle cerebral artery occlusion (tMCAO) model in male C57BL/6J mice and <em>in vitro</em> using an oxygen-glucose deprivation/reperfusion (OGD/R) model in Neuro-2a mouse neuroblastoma cells.</div></div><div><h3>Results</h3><div>High-mobility group box 1 (HMGB1) was identified as a key target of DSS-S. Following I/R or OGD/R, levels of IL-1β, IL-6, TNF-α, IL-18, and HMGB1 were significantly elevated in both mouse serum and cell culture supernatant, and these increases were substantially attenuated by DSS-S treatment. DSS-S reduced cytoplasmic HMGB1 accumulation, promoted its nuclear retention, down-regulated the receptor for advanced glycation end-products (RAGE), and weakened the HMGB1-RAGE interaction. Pyroptosis was activated in both tMCAO and OGD/R models, and DSS-S intervention effectively inhibited pyroptosis by suppressing the HMGB1/RAGE signaling pathway and NLRP3 inflammasome activation.</div></div><div><h3>Conclusion</h3><div>DSS-S exerts neuroprotective effects against cerebral I/R injury <em>in vivo</em> and reduces OGD/R-induced injury <em>in vitro</em>. The protection is mediated through inhibition of pyroptosis, achieved by targeting the HMGB1/RAGE axis and suppressing NLRP3 inflammasome activation.</div></div>","PeriodicalId":297,"journal":{"name":"Cytokine","volume":"199 ","pages":"Article 157109"},"PeriodicalIF":3.6000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cytokine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1043466626000049","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Danshensu Sodium (DSS-S), the sodium salt of a principal water-soluble active compound from Salvia miltiorrhiza, was investigated for its effects on cerebral ischemic-reperfusion (I/R) injury and the underlying molecular mechanisms.
Methods
Neuroprotection by DSS-S was evaluated in vivo using a transient middle cerebral artery occlusion (tMCAO) model in male C57BL/6J mice and in vitro using an oxygen-glucose deprivation/reperfusion (OGD/R) model in Neuro-2a mouse neuroblastoma cells.
Results
High-mobility group box 1 (HMGB1) was identified as a key target of DSS-S. Following I/R or OGD/R, levels of IL-1β, IL-6, TNF-α, IL-18, and HMGB1 were significantly elevated in both mouse serum and cell culture supernatant, and these increases were substantially attenuated by DSS-S treatment. DSS-S reduced cytoplasmic HMGB1 accumulation, promoted its nuclear retention, down-regulated the receptor for advanced glycation end-products (RAGE), and weakened the HMGB1-RAGE interaction. Pyroptosis was activated in both tMCAO and OGD/R models, and DSS-S intervention effectively inhibited pyroptosis by suppressing the HMGB1/RAGE signaling pathway and NLRP3 inflammasome activation.
Conclusion
DSS-S exerts neuroprotective effects against cerebral I/R injury in vivo and reduces OGD/R-induced injury in vitro. The protection is mediated through inhibition of pyroptosis, achieved by targeting the HMGB1/RAGE axis and suppressing NLRP3 inflammasome activation.
期刊介绍:
The journal Cytokine has an open access mirror journal Cytokine: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review.
* Devoted exclusively to the study of the molecular biology, genetics, biochemistry, immunology, genome-wide association studies, pathobiology, diagnostic and clinical applications of all known interleukins, hematopoietic factors, growth factors, cytotoxins, interferons, new cytokines, and chemokines, Cytokine provides comprehensive coverage of cytokines and their mechanisms of actions, 12 times a year by publishing original high quality refereed scientific papers from prominent investigators in both the academic and industrial sectors.
We will publish 3 major types of manuscripts:
1) Original manuscripts describing research results.
2) Basic and clinical reviews describing cytokine actions and regulation.
3) Short commentaries/perspectives on recently published aspects of cytokines, pathogenesis and clinical results.